drugset / Trial / NCT00042991

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

NCT00042991

Phase 1/2 Completed 69 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Biological therapies such as gefitinib may interfere with the growth of the tumor cells and may make the tumor cells more sensitive to radiation therapy. This phase I/II trial is studying how well giving gefitinib together with radiation therapy works in treating children with newly diagnosed glioma.

Timeline

Start
2002-07
Primary completion
2010-02
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Gefitinib Small molecule Oral